Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1990;81:1887-1898

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yokota, M.
Right arrow Articles by Takeuchi, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yokota, M.
Right arrow Articles by Takeuchi, J.

Circulation, Vol 81, 1887-1898, Copyright © 1990 by American Heart Association


ARTICLES

Hemodynamic mechanisms of antianginal action of calcium channel blocker nisoldipine in dynamic exercise-induced angina

M Yokota, T Miyahara, M Iwase, M Watanabe, T Matsunami, S Kamihara, M Koide, H Saito and J Takeuchi
Department of Clinical Laboratory, Nagoya University Hospital, Japan.

To investigate the mechanism of antianginal action of the calcium channel blocker nisoldipine and to determine the reproducibility of the clinical and hemodynamic events induced by supine leg exercise, 30 patients with stable effort angina pectoris were studied. They were divided into two groups; one group of 19 patients received a single 10- mg dose of nisoldipine orally, and the other group of 11 patients received a single dose of placebo orally. Chest pain was induced in all of 30 patients during the control exercise test. After nisoldipine administration, chest pain was not induced in 13 of 19 patients and was of lessened severity in five patients with the same work load as those performing control exercise. ST segment at peak exercise showed less severe depression after nisoldipine. Systemic vascular resistance was reduced by 38% (p less than 0.001) at rest and 22% (p less than 0.001) at peak exercise, and coronary vascular resistance was reduced by 31% (p less than 0.01) at rest and 18% (p less than 0.01) at peak exercise. Pulmonary artery wedge pressure fell from 6 +/- 1 to 3 +/- 1 mm Hg (p less than 0.001) at rest and from 28 +/- 3 to 11 +/- 2 mm Hg (p less than 0.001) at peak exercise. Coronary sinus flow at rest and myocardial oxygen uptake both at rest and during exercise was not modified by nisoldipine. However, coronary sinus flow at peak exercise increased significantly from 219 +/- 24 to 249 +/- 31 ml/min (p less than 0.01) after nisoldipine, and myocardial oxygen uptake was not significantly changed despite decreased coronary vascular resistance. The clinical and hemodynamic events induced by the exercise during invasive studies (except pulmonary artery wedge pressure at rest) were reproducible after placebo administration. Our data demonstrate that increased coronary blood flow could be the major mechanism of the antianginal action of nisoldipine in supine leg exercise-induced angina.


This article has been cited by other articles:


Home page
CirculationHome page
M. Inagaki, M. Yokota, H. Izawa, R. Ishiki, K. Nagata, M. Iwase, Y. Yamada, M. Koide, and T. Sobue
Impaired Force-Frequency Relations in Patients With Hypertensive Left Ventricular Hypertrophy : A Possible Physiological Marker of the Transition From Physiological to Pathological Hypertrophy
Circulation, April 13, 1999; 99(14): 1822 - 1830.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
H. Izawa, M. Yokota, Y. Takeichi, M. Inagaki, K. Nagata, M. Iwase, and T. Sobue
Adrenergic Control of the Force-Frequency and Relaxation-Frequency Relations in Patients With Hypertrophic Cardiomyopathy
Circulation, November 4, 1997; 96(9): 2959 - 2968.
[Abstract] [Full Text]


Home page
CirculationHome page
P. B.M. Clarkson, N. M. Wheeldon, R. J. MacFadyen, S. D. Pringle, and T. M. MacDonald
Effects of Brain Natriuretic Peptide on Exercise Hemodynamics and Neurohormones in Isolated Diastolic Heart Failure
Circulation, June 1, 1996; 93(11): 2037 - 2042.
[Abstract] [Full Text]